Minireviews
Copyright ©The Author(s) 2021.
World J Cardiol. Oct 26, 2021; 13(10): 556-565
Published online Oct 26, 2021. doi: 10.4330/wjc.v13.i10.556
Table 1 Cardiac involvement in coronavirus disease 2019 patients among various studies
Ref.
Study type
Number of patients
Cardiac involvement
Cardiovascular comorbidities
Wang et al[2]Case series1387.2%Diabetes (10.1%); Hypertension (31.2%); CVD (14.5%); CVA
Huang et al[4]Prospective 4112%Hypertension
Guo et al[8]Retrospective 18727.8%Hypertension (32.6%); Diabetes (15%); CVD (11.2%); Cardiomyopathy (4.3%)
Zhou et al[12]Retrospective19117%Hypertension (30%); Diabetes (19%); CAD (8%)
Shi et al[25]Descriptive41619.7%Hypertension (30.5%); Diabetes (14.4%); CVA (5.3%); CAD (10.6%)
Yang et al[33]Retrospective, observational study5223%Diabetes (17%); CVD (10%); CVA (13.5%)
Table 2 Modified venous thrombo-embolism score for risk stratification in pulmonary embolism/deep vein thrombosis
VTE risk factor
VTE risk score
Previous VTE3
Known thrombophilia12
Current lower limb paralysis or paresis2
History of cancer2
ICU/CCU stay 1
Complete immobilization > 24 h1
Age > 60 yr1